| 2025-07-22 |
详情>>
内部人交易：
Coelho Mary Theresa等共交易2笔
|
| 2025-07-19 |
复牌提示：
2025-07-18 16:01:00 停牌，复牌日期 2025-07-18 16:35:00
|
| 2025-07-03 |
股东大会：
将于2025-07-29召开股东大会
会议内容 ▼▲
- 1.To consider and vote upon a proposal to approve the sale of certain assets of the Company (the “Asset Sale”) pursuant to the Asset Purchase Agreement dated May 21, 2025 (as it may be amended from time to time, the “Asset Purchase Agreement”), by and among HOOKIPA, Hookipa Biotech GmbH and Gilead Sciences, Inc. (the “Asset Sale Proposal”).
2.To approve the liquidation and dissolution of the Company (the “Dissolution”) and the Plan of Dissolution (as it may be amended from time to time, the “Plan of Dissolution”), which, if approved, will authorize the Company to dissolve and liquidate as described in the Plan of Dissolution (the “Dissolution Proposal”).
3.To approve one or more adjournments of the Special Meeting from time to time, if necessary, to solicit additional proxies in the event that there are insufficient shares present virtually or represented by proxy voting in favor of the Asset Sale Proposal or the Dissolution Proposal (the “Adjournment Proposal”).
|
| 2025-07-03 |
详情>>
股本变动：
变动后总股本1219.86万股
|
| 2025-05-15 |
详情>>
业绩披露：
2025年一季报每股收益-1.23美元,归母净利润-1542.7万美元,同比去年增长-207.26%
|
| 2025-02-28 |
详情>>
业绩披露：
2024年年报每股收益-3.47美元,归母净利润-4350.3万美元,同比去年增长46.67%
|
| 2025-02-28 |
详情>>
业绩披露：
2022年年报每股收益-9.91美元,归母净利润-6491.5万美元,同比去年增长14.21%
|
| 2024-11-14 |
详情>>
业绩披露：
2024年三季报(累计)每股收益-1.48美元,归母净利润-1855.3万美元,同比去年增长67.31%
|
| 2024-08-08 |
详情>>
业绩披露：
2024年中报每股收益-0.38美元,归母净利润-471.2万美元,同比去年增长87.50%
|
| 2024-07-10 |
详情>>
拆分方案：
每10.0000合并分成1.0000股
|
| 2024-05-09 |
详情>>
业绩披露：
2024年一季报每股收益0.11美元,归母净利润1438.30万美元,同比去年增长173.08%
|
| 2024-04-26 |
股东大会：
将于2024-06-17召开股东大会
会议内容 ▼▲
- 1.To elect Timothy Reilly, Ph.D., and Malte Peters as Class II members of the Board of Directors, to serve until the Company’s 2027 Annual Meeting of Stockholders and until their successors are duly elected and qualified (“Proposal 1—Director Elections”);
2.To ratify the selection of PwC Wirtschaftsprüfung GmbH as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2024(“Proposal 2—Auditor Ratification”);
3.To approve an amendment to the Company’s Amended and Restated Certificate of Incorporation to increase the total number of authorized shares of common stock from 200,000,000 shares to 400,000,000 shares(“Proposal 3—Authorized Stock Increase Proposal”);
4.To authorize an amendment to the Company’s Amended and Restated Certificate of Incorporation to effect a reverse stock split of the Company’s common stock (with a proportionate reduction in the authorized number of shares of Company common stock), in the range of 1-for-2 to 1-for-10 at any time prior to June 17, 2025, if and as determined by the Company’s board of directors(“Proposal 4—Reverse Split Proposal”).The Board of Directors may alternatively elect to abandon such proposed amendment and not effect the reverse stock split authorized by stockholders, in its sole discretion;
5.To transact any other business that may properly come before the meeting or any adjournment thereof.
|
| 2024-03-22 |
详情>>
业绩披露：
2021年年报每股收益-2.3美元,归母净利润-7566.5万美元,同比去年增长-71.65%
|
| 2024-03-22 |
详情>>
业绩披露：
2023年年报每股收益-0.86美元,归母净利润-8158万美元,同比去年增长-25.67%
|
| 2023-11-09 |
详情>>
业绩披露：
2023年三季报(累计)每股收益-0.64美元,归母净利润-5676.2万美元,同比去年增长-7.9%
|
| 2023-11-09 |
财报披露：
美东时间 2023-11-09 盘前发布财报
|
| 2023-08-10 |
详情>>
业绩披露：
2023年中报每股收益-0.49美元,归母净利润-3769.6万美元,同比去年增长-9.82%
|
| 2023-05-11 |
详情>>
业绩披露：
2023年一季报每股收益-0.27美元,归母净利润-1968万美元,同比去年增长-9.53%
|
| 2023-04-13 |
股东大会：
将于2023-06-09召开股东大会
会议内容 ▼▲
- 1.To elect Joern Aldag, Jan Van de Winkel and David Kaufman as Class I members of the Board of Directors, to serve until the Company’s 2026 Annual Meeting of Stockholders and until their successors are duly elected and qualified (“Proposal One—Director Elections”);
2.To ratify the selection of PwC Wirtschaftsprüfung GmbH as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2023 (“Proposal Two—Auditor Ratification”);
3.To transact any other business that may properly come before the Annual Meeting or any adjournment or postponement thereof.
|
| 2022-05-16 |
股东大会：
将于2022-06-30召开股东大会
会议内容 ▼▲
- 1.the election of two Class III directors for three-year terms;
2.the ratification of the appointment of PwC Wirtschaftsprüfung GmbH as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2022;
3.the authorization to amend our certificate of incorporation to increase the total number of authorized shares of common stock from 100,000,000 shares to 200,000,000 shares;
4.the authorization of an amendment to the Company’s Amended and Restated Certificate of Incorporation to effect a reverse stock split of Company common stock (without reducing the authorized number of shares of Company common stock), in the range of 1-for-2 to 1-for-10 share if and when determined by the Company’s board of directors;
5.the approval of an amendment to the Company’s 2019 Stock Option and Incentive Plan.
|
| 2021-09-06 |
温馨提示：
美股因劳工节，9月6日休市一天
|
| 2021-04-20 |
股东大会：
将于2021-06-01召开股东大会
会议内容 ▼▲
- 1.To elect Jean-Charles Soria and Michael A. Kelly as Class II members of the Board of Directors, to serve until the Company’s 2024 Annual Meeting of Stockholders and until their successors are duly elected and qualified;
2.To ratify the selection of PwC Wirtschaftsprüfung GmbH as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2021;
3.To transact any other business that may properly come before the meeting or any adjournment thereof.
|
| 2020-04-28 |
股东大会：
将于2020-06-18召开股东大会
会议内容 ▼▲
- 1.To elect Joern Aldag, Jan van de Winkel and David R. Kaufman as Class I members of the Board of Directors, to serve until the Company's 2023 Annual Meeting of Stockholders and until their successors are duly elected and qualified;
2.To ratify the selection of PwC Wirtschaftsprüfung GmbH as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2020;
3.To transact any other business that may properly come before the meeting or any adjournment thereof.
|